Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Hypercoagulability by Thrombin Generation Test in Beta-thalassemia Major

NCT04962984 is registered in ClinicalTrials.gov with Central Hospital, Nancy, France as lead sponsor.

NCT NCT04962984
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04962984 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Hypercoagulability by Thrombin Generation Test in Beta-thalassemia Major
Lead sponsor
Central Hospital, Nancy, France
Phase
Not applicable
Overall status
Unknown status
Start date
September 1, 2021
Completion date
September 1, 2024
Enrollment
45 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

beta thalassemia major anemia